The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP
about
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraPeripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancerPrognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensThe preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy.The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.
P2860
Q33558130-235D28A3-C60E-4201-BF17-508D5514EC5CQ33662640-80720B3A-48DB-4A2D-9F29-27F269D8D19BQ33701858-26A13A56-BB72-4411-AE85-FE1FC1309CA4Q35152328-89AE74DF-8C25-48CA-8F6F-188D8D600572Q36673451-54C6A173-1334-4467-9345-79ACA7099F81Q37507488-92D9E507-017C-4452-AD23-FC55B1A2BF91Q41120596-72A2D79B-231A-4A2F-B01E-21168146DD18Q41148150-26D99876-61EF-4B00-83EC-F2EC6AF8A709Q43754838-E4B88339-5BA8-4776-A108-36D56B8CD5BAQ44404015-C82487C0-3234-4595-A9AF-0BA877604BC1Q45216334-E9DDC4CD-CBD1-40D2-A887-6DB0BF72DBE0Q48654812-36F9EA90-631A-43D3-8979-902C884A2521Q53090405-A67219C4-BEC3-4C6C-837F-CDFD4F94CA6CQ54957513-4C39754E-84A4-4B34-9FEC-EAF8F224D5CA
P2860
The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@ast
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@en
type
label
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@ast
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@en
prefLabel
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@ast
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@en
P2093
P2860
P1476
The absolute monocyte and lymp ...... ll lymphoma who receive R-CHOP
@en
P2093
Anas Younes
Elham Ghonimi
Felipe Samaniego
Fredrick B Hagemeister
Jorge Enrique Romaguera
Larry W Kwak
Luis Fayad
Maria Alma Rodriguez
Nicolas Batty
P2860
P356
10.1016/J.CLML.2012.09.009
P407
P577
2012-11-06T00:00:00Z